Literature DB >> 28712463

Vaccines in development for the primary prevention of Clostridium difficile infection.

Laurel M Legenza, Susanne G Barnett, Warren E Rose.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28712463     DOI： 10.1016/j.japh.2017.06.007

Source DB:  PubMed          Journal:  J Am Pharm Assoc (2003)        ISSN： 1086-5802


× No keyword cloud information.
  3 in total

Review 1.  Battling Enteropathogenic Clostridia: Phage Therapy for Clostridioides difficile and Clostridium perfringens.

Authors:  Jennifer Venhorst; Jos M B M van der Vossen; Valeria Agamennone
Journal:  Front Microbiol       Date:  2022-06-13       Impact factor: 6.064

2.  To study the contributing factors and outcomes of Clostridioides difficile infection in patients with solid tumors.

Authors:  Kamal Kant Sahu; Ajay Kumar Mishra; Vishal Jindal; Ahmad Daniyal Siddiqui; Susan V George
Journal:  Heliyon       Date:  2021-11-26

3.  Frontiers in antibiotic alternatives for Clostridioides difficile infection.

Authors:  Matthew Phanchana; Phurt Harnvoravongchai; Supapit Wongkuna; Tanaporn Phetruen; Wichuda Phothichaisri; Supakan Panturat; Methinee Pipatthana; Sitthivut Charoensutthivarakul; Surang Chankhamhaengdecha; Tavan Janvilisri
Journal:  World J Gastroenterol       Date:  2021-11-14       Impact factor: 5.742
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.